90 related articles for article (PubMed ID: 26324025)
1. A novel mutation in SIRT1-AS leading to a decreased risk of HCC.
Liu J; Wu W; Jin J
Oncol Rep; 2015 Nov; 34(5):2343-50. PubMed ID: 26324025
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-29c functions as a tumor suppressor by direct targeting oncogenic SIRT1 in hepatocellular carcinoma.
Bae HJ; Noh JH; Kim JK; Eun JW; Jung KH; Kim MG; Chang YG; Shen Q; Kim SJ; Park WS; Lee JY; Nam SW
Oncogene; 2014 May; 33(20):2557-67. PubMed ID: 23728341
[TBL] [Abstract][Full Text] [Related]
3. miR-204-5p targeting SIRT1 regulates hepatocellular carcinoma progression.
Jiang G; Wen L; Zheng H; Jian Z; Deng W
Cell Biochem Funct; 2016 Oct; 34(7):505-510. PubMed ID: 27748572
[TBL] [Abstract][Full Text] [Related]
4. [Growth inhibition of human hepatocellular carcinoma by miRNA-204 via down-regulation of Bcl-2 and Sirt1 expression].
Li K; Xyu Q; Liu X; Liu Q; Wang M
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Feb; 31(2):168-72. PubMed ID: 25652855
[TBL] [Abstract][Full Text] [Related]
5. LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells.
Xiong H; Ni Z; He J; Jiang S; Li X; He J; Gong W; Zheng L; Chen S; Li B; Zhang N; Lyu X; Huang G; Chen B; Zhang Y; He F
Oncogene; 2017 Jun; 36(25):3528-3540. PubMed ID: 28166203
[TBL] [Abstract][Full Text] [Related]
6. Identification, stability and expression of Sirt1 antisense long non-coding RNA.
Wang Y; Pang WJ; Wei N; Xiong Y; Wu WJ; Zhao CZ; Shen QW; Yang GS
Gene; 2014 Apr; 539(1):117-24. PubMed ID: 24480449
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of SIRT1 promotes metastasis through epithelial-mesenchymal transition in hepatocellular carcinoma.
Hao C; Zhu PX; Yang X; Han ZP; Jiang JH; Zong C; Zhang XG; Liu WT; Zhao QD; Fan TT; Zhang L; Wei LX
BMC Cancer; 2014 Dec; 14():978. PubMed ID: 25522783
[TBL] [Abstract][Full Text] [Related]
8. SIRT1 regulates oncogenesis via a mutant p53-dependent pathway in hepatocellular carcinoma.
Zhang ZY; Hong D; Nam SH; Kim JM; Paik YH; Joh JW; Kwon CH; Park JB; Choi GS; Jang KY; Park CK; Kim SJ
J Hepatol; 2015 Jan; 62(1):121-30. PubMed ID: 25131770
[TBL] [Abstract][Full Text] [Related]
9. Sirt1 AS lncRNA interacts with its mRNA to inhibit muscle formation by attenuating function of miR-34a.
Wang GQ; Wang Y; Xiong Y; Chen XC; Ma ML; Cai R; Gao Y; Sun YM; Yang GS; Pang WJ
Sci Rep; 2016 Feb; 6():21865. PubMed ID: 26902620
[TBL] [Abstract][Full Text] [Related]
10. SIRT1 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma and its expression predicts poor prognosis.
Chen HC; Jeng YM; Yuan RH; Hsu HC; Chen YL
Ann Surg Oncol; 2012 Jun; 19(6):2011-9. PubMed ID: 22146883
[TBL] [Abstract][Full Text] [Related]
11. Association between an insertion/deletion polymorphism within 3'UTR of SGSM3 and risk of hepatocellular carcinoma.
Wang C; Zhao H; Zhao X; Wan J; Wang D; Bi W; Jiang X; Gao Y
Tumour Biol; 2014 Jan; 35(1):295-301. PubMed ID: 23918301
[TBL] [Abstract][Full Text] [Related]
12. A miR-1231 binding site polymorphism in the 3'UTR of IFNAR1 is associated with hepatocellular carcinoma susceptibility.
Zhou C; Yu Q; Chen L; Wang J; Zheng S; Zhang J
Gene; 2012 Oct; 507(1):95-8. PubMed ID: 22824466
[TBL] [Abstract][Full Text] [Related]
13. Expression and role of SIRT1 in hepatocellular carcinoma.
Choi HN; Bae JS; Jamiyandorj U; Noh SJ; Park HS; Jang KY; Chung MJ; Kang MJ; Lee DG; Moon WS
Oncol Rep; 2011 Aug; 26(2):503-10. PubMed ID: 21567102
[TBL] [Abstract][Full Text] [Related]
14. Sirt1 antisense transcript is down-regulated in human tumors.
Mokhberian N; Hashemi SM; Jajarmi V; Eftekhary M; Koochaki A; Ghanbarian H
Mol Biol Rep; 2019 Apr; 46(2):2299-2305. PubMed ID: 30756332
[TBL] [Abstract][Full Text] [Related]
15. Emerging role of silent information regulator 1 (SIRT1) in hepatocellular carcinoma: a potential therapeutic target.
Wu Y; Meng X; Huang C; Li J
Tumour Biol; 2015 Jun; 36(6):4063-74. PubMed ID: 25926383
[TBL] [Abstract][Full Text] [Related]
16. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of miR-181a upregulates sirtuin-1 (SIRT1) and improves hepatic insulin sensitivity.
Zhou B; Li C; Qi W; Zhang Y; Zhang F; Wu JX; Hu YN; Wu DM; Liu Y; Yan TT; Jing Q; Liu MF; Zhai QW
Diabetologia; 2012 Jul; 55(7):2032-43. PubMed ID: 22476949
[TBL] [Abstract][Full Text] [Related]
18. Sirtuin 1 is upregulated in a subset of hepatocellular carcinomas where it is essential for telomere maintenance and tumor cell growth.
Chen J; Zhang B; Wong N; Lo AW; To KF; Chan AW; Ng MH; Ho CY; Cheng SH; Lai PB; Yu J; Ng HK; Ling MT; Huang AL; Cai XF; Ko BC
Cancer Res; 2011 Jun; 71(12):4138-49. PubMed ID: 21527554
[TBL] [Abstract][Full Text] [Related]
19. No association of pre-microRNA-146a rs2910164 polymorphism and risk of hepatocellular carcinoma development in Turkish population: a case-control study.
Akkız H; Bayram S; Bekar A; Akgöllü E; Usküdar O; Sandıkçı M
Gene; 2011 Oct; 486(1-2):104-9. PubMed ID: 21807077
[TBL] [Abstract][Full Text] [Related]
20. Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
Han Y; Pu R; Han X; Zhao J; Li W; Yin J; Zhang Y; Shen Q; Xie J; Zhang Q; Jiang S; Li J; Zhang H; Wang H; Cao G
Liver Int; 2014 May; 34(5):728-36. PubMed ID: 24118778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
